Search research articles
Contact Us
Filters
Showing results (311-320 of 367) with videos related to
Page
of 37
Sort By:
World Journal of Gastroenterology
|
August 30, 2014
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
Chun-Jen Liu, Juliana Chang, Po-Huang Lee, et al.
Hepatology (Baltimore, Md.)
|
January 17, 2013
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
Ming-Lung Yu, Chuan-Mo Lee, Chi-Ling Chen, et al.
Annals of Internal Medicine
|
December 4, 2013
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial
Chen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B
Man-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, et al.
Alimentary Pharmacology & Therapeutics
|
July 5, 2019
Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers
Kai-Chi Chang, Mei-Hwei Chang, Chien-Nan Lee, et al.
Gut
|
January 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease
Yu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng, et al.
Gastroenterology
|
December 17, 2008
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
Chun-Jen Liu, Wan-Long Chuang, Chuan-Mo Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 5, 2021
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
Chun Jen Liu, I Shyan Sheen, Chi Yi Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 8, 2024
Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes
Huey-Ling Chen, Chien-Nan Lee, Chin-Hao Chang, et al.
Gut
|
April 22, 2014
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
Chen-Hua Liu, Chun-Jen Liu, Chung-Feng Huang, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 367) with videos related to
Sort By:
Page
of 37
World Journal of Gastroenterology
|
August 30, 2014
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
Chun-Jen Liu, Juliana Chang, Po-Huang Lee, et al.
Hepatology (Baltimore, Md.)
|
January 17, 2013
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
Ming-Lung Yu, Chuan-Mo Lee, Chi-Ling Chen, et al.
Annals of Internal Medicine
|
December 4, 2013
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial
Chen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B
Man-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, et al.
Alimentary Pharmacology & Therapeutics
|
July 5, 2019
Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers
Kai-Chi Chang, Mei-Hwei Chang, Chien-Nan Lee, et al.
Gut
|
January 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease
Yu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng, et al.
Gastroenterology
|
December 17, 2008
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
Chun-Jen Liu, Wan-Long Chuang, Chuan-Mo Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 5, 2021
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
Chun Jen Liu, I Shyan Sheen, Chi Yi Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 8, 2024
Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes
Huey-Ling Chen, Chien-Nan Lee, Chin-Hao Chang, et al.
Gut
|
April 22, 2014
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
Chen-Hua Liu, Chun-Jen Liu, Chung-Feng Huang, et al.
Page
of 37